Hamster preproglucagon contains the sequence of glucagon and two related peptides
The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Abstract
Glucagon is a 29-amino acid polypeptide hormone synthesized by the A cells of the endocrine pancreas. Its primary site of action is the liver where it stimulates glycogenolysis, gluconeogenesis and ketogenesis. In mammals, biosynthetic studies have shown that glucagon is derived from a precursor of molecular weight (Mr) approximately 18,000 which is five to six times larger than glucagon. Glucagon-containing polypeptides and immunoreactants of various sizes have also been described from stomach, intestine, brain and salivary gland. Here, we have determined the structure of hamster pancreatic preproglucagon from the sequence of its cDNA. This 180-amino acid precursor contains the sequence of glucagon and two glucagon-like polypeptides arranged in tandem. The precursor also contains the sequences of several non-pancreatic glucagon-containing polypeptides which suggests that, in mammals, both pancreatic and non-pancreatic glucagon and glucagon-containing polypeptides may be derived from a common precursor by tissue-specific processing. We have tentatively identified each of the glucagon-like immunoreactants which have been described with respect to the sequence of proglucagon and have proposed a scheme for the processing of pancreatic proglucagon.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In fact, GIP-driven weight loss is synergistically enhanced by adjunct GLP-1R agonism47-49”
From Transforming obesity: The advancement of multi-receptor drugs (2024) · cites this paper as [48]
In the citing paper
“This highlighted for the first time that supplemental GLP-1R/GIPR co-agonism could greatly outperform GLP-1R mono-agonism, to achieve greater weight loss and elicit further improvements in glucose homeostasis48.”
From Transforming obesity: The advancement of multi-receptor drugs (2024) · cites this paper as [48]
In the citing paper
“GIPR agonist treatment is equally effective in promoting weight loss in obese mice”
From Transforming obesity: The advancement of multi-receptor drugs (2024) · cites this paper as [48]
In the citing paper
“MAR709 successfully completed Phase 1 clinical trials with good tolerability48,124,125, concomitant with a meaningful reduction in body weight and HbA1c levels in subjects with T2D48,125.”
From Transforming obesity: The advancement of multi-receptor drugs (2024) · cites this paper as [48]
In the citing paper
“There are two notable unimolecular GLP-1R/GIPR co-agonist peptides that have been preclinically and clinically most characterized to display enhanced glucose-lowering potential, superior weight loss and appetite suppression, when evaluated with comparable GLP-1R agonists.”
From Transforming obesity: The advancement of multi-receptor drugs (2024) · cites this paper as [48]
8 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease
Chirgwin, J. M., Przybyla, A. E., MacDonald, R. J., & Rutter, W. J. (1979) · Biochemistry · doi:10.1021/bi00591a005 · Cited by 21,725
[57] Sequencing end-labeled DNA with base-specific chemical cleavages
Maxam, A. M., & Gilbert, W. (1980) · Methods in Enzymology · doi:10.1016/s0076-6879(80)65059-9 · Cited by 14,315
Hybridization of denatured RNA and small DNA fragments transferred to nitrocellulose.
Thomas, P. S. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.9.5201 · Cited by 8,156
Atlas of protein sequence and structure
Chang, M.-Y., Dayhoff, M. O., Eck, R. V., & Sochard, M. R. (1965) · NASA Technical Reports Server (NASA) · Cited by 4,383
3′ Non-coding region sequences in eukaryotic messenger RNA
Proudfoot, N. J., & Brownlee, G. G. (1976) · Nature · doi:10.1038/263211a0 · Cited by 2,968
Deoxynucleoside phosphoramidites—A new class of key intermediates for deoxypolynucleotide synthesis
Beaucage, S. L., & Caruthers, M. H. (1981) · Tetrahedron Letters · doi:10.1016/s0040-4039(01)90461-7 · Cited by 1,993
Atlas of Protein Sequence and Structure, 1966.
Hersh, R. T., Eck, R. V., & Dayhoff, M. O. (1967) · Systematic Zoology · doi:10.2307/2412074 · Cited by 1,779
Growth Hormone-Releasing Factor from a Human Pancreatic Tumor That Caused Acromegaly
Guillemin, R., Brazeau, P., Bohlen, P., Esch, F., Ling, N., & Wehrenberg, W. B. (1982) · Science · doi:10.1126/science.6812220 · Cited by 1,294
The sequence 5′-AAUAAA-3′ forms part of the recognition site for polyadenylation of late SV40 mRNAs
Fitzgerald, M. (1981) · Cell · doi:10.1016/0092-8674(81)90521-3 · Cited by 776
Primary structure of the human Met- and Leu-enkephalin precursor and its mRNA
Comb, M., Seeburg, P. H., Adelman, J., Eiden, L., & Herbert, E. (1982) · Nature · doi:10.1038/295663a0 · Cited by 679
Research works printed but not linked: 1
- Unger, R.H. & Orei, L. (eds) Glucagon. Physiology, Pathophysiology and Morphology of the Pancreatic A-Cell (Elsevier, New York, 1981).
Cited by
Items 501–600 of 645
The Discovery and Development of Glucagon-Like Peptide-1 Receptor Agonists
Fang, H., Niu, B., & Chen, Q. (2023) · Current Medicinal Chemistry · doi:10.2174/0929867330666230416153301 · Cited by 3
The progress of luminescent assay in clinical diagnosis and treatment of diabetes mellitus
Fang, C., Li, H., & Tu, Y. (2016) · Journal of Electroanalytical Chemistry · doi:10.1016/j.jelechem.2016.07.021 · Cited by 3
Pharmacology of Gut Hormone Mimetics for Obesity and Diabetes
Lafferty, R. A., O'Harte, F. P. M., Irwin, N., Flatt, P. R., & Gault, V. A. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820472-6.00035-9 · Cited by 3
Microscopic Anatomy of the Human Islet of Langerhans
Veld, P. I. '., & Smeets, S. (2014) · Springer eBooks · doi:10.1007/978-94-007-6884-0_1-2 · Cited by 5
Tammen, H., Forssmann, W., & Richter, R. (1999) · Journal of Chromatography A · doi:10.1016/s0021-9673(99)00389-1 · Cited by 3
Potential of GLP-1 in Diabetes Management
Holst, J. J., Nauck, M. A., Deacon, C. F., & Ørskov, C. (1996) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-61150-6_18 · Cited by 3
Chapter 7 Molecular aspects of the glucagon gene
Laser, B., & Philippé, J. (1997) · Advances in molecular and cellular endocrinology · doi:10.1016/s1569-2566(97)80038-5 · Cited by 9
STRUCTURE OF PRECURSORS DERIVED FROM THE SEQUENCES OF CLONED cDNAs
Rutter, W. J., Scott, J., Selby, M., Crawford, R. J., Shen, L., Hobart, P. M., Sánchez-Pescador, R., & Bell, G. I. (1983) · Elsevier eBooks · doi:10.1016/b978-0-12-417320-0.50028-7 · Cited by 3
Self-citationEditorial: Proglucagon-Derived Peptides
Flatt, P. R., Knop, F. K., & Tarasov, A. I. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.776871 · Cited by 3
Special Issue: “Anti-inflammatory Effects of Glucagon-like Peptide-1”
Puddu, A., & Maggi, D. C. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25041997 · Cited by 7
Impaired Incretin Homeostasis in Nondiabetic Moderate-to-Severe CKD
Ahmadi, A., Gamboa, J. L., Norman, J., Enkhmaa, B., Tucker, M., Bennett, B. J., Zelnick, L. R., Fan, S., Berglund, L., Ikizler, T. A., et al. (2024) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.0000000000000566 · Cited by 2
“The percent change in glucagon levels from baseline to 30 minutes after OGTT was attenuated in patients with CKD with a median (interquartile range [IQR]) of 2 27% [ 2 11 to 2 46] versus 2 38% [ 2 19 to 2 57] among controls.”
Carpio, L. E., Olivares, M., Ortega-Vallbona, R., Serrano‐Candelas, E., Sanz, Y., & Gozalbes, R. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26125579 · Cited by 2
Helal, M. M., Almosilhy, N. A., Abo‐elnour, D. E., Jaffal, R., Allam, E. G., Almosilhy, M. A., Batarseh, S. F., & Meshref, M. M. (2026) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.1080/21678421.2026.2627901 · Cited by 3
“The following year, Graeme Bell and colleagues successfully cloned and sequenced the pre-proglucagon gene, identifying glucagon-like peptide-1 (GLP-1) and glucagon-like peptide-2 (GLP-2) (173,174).”
Incretin-Based Therapies: A Novel Pathway in Addiction Treatment
Rosiejka, D., Joanna, M., Marcickiewicz, J., Bogdańska, A., Błażejewska, W., & Szulińska, M. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15041613 · Cited by 2
“During the 1980s, Graeme Bell and colleagues elucidated the structure of proglucagon, discovering several previously unrecognized peptides, including GLP-1 and GLP-2, which are secreted from the intestinal mucosa [26,27].”
From the Discovery of GLP-1 to Today’s Diabetes/Obesity Therapy and Beyond
Holst, J. J. (2026) · Biological Psychiatry · doi:10.1016/j.biopsych.2026.04.010 · Cited by 3
Liao, K., Tsai, Y., Κostikas, Κ., Criner, G. J., Wu, J.-Y., & Lai, C. (2026) · QJM · doi:10.1093/qjmed/hcag217 · Cited by 2
Glucose acts as a ligand for glucokinase to trigger postprandial secretion of GLP-1
Li, C., Li, M., Yang, H.-Y., Tian, X., Zhang, C., Zhao, L., Wu, J., Zhang, C., Liu, S., Yang, X., et al. (2026) · Vita · doi:10.15302/vita.2026.07.0059 · Cited by 2
Israelitisches Krankenhaus in Hamburg
Lehrkrankenhaus, A. (2014) · Cited by 2
Glucagon receptor family in GtoPdb v.2023.1
BATAILLE, D., Chan, S. L. F., Delagrange, P., Drucker, D. J., Göke, B., Hills, R., Mayo, K. E., Miller, L. J., Salvatori, R., & Thorens, B. (2023) · IUPHAR/BPS Guide to Pharmacology CITE · doi:10.2218/gtopdb/f29/2023.1 · Cited by 2
Li, S., Guan, C., Wang, Y., Chen, H., Li, W., Wang, S., Zhang, C., & Xing, X. (2024) · Food Science and Human Wellness · doi:10.26599/fshw.2024.9250206 · Cited by 2
“The discovery of glucagon-like peptide-1 (GLP-1), an intestinal hormone involved in glucose homeostasis [4,5],and a DPP-IV substrate [6–8] has highlighted the role of DPP-IV in glycemic regulation.”
Nair, P. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2416868121 · Cited by 2
A Novel Regulator of the Pancreatic Islet Physiology
Lajoix, A., Brigand, L. L., Dufour, M., Le‐Nguyen, D., & BATAILLE, D. (2002) · Cited by 2
Pancreatic Glucagon-Like Peptide 1: What is known?
Fava, G. E. (2014) · Journal of Diabetes & Metabolism · doi:10.4172/2155-6156.1000397 · Cited by 2
“Glucagon-like peptide-1 (GLP-1) is one of the peptide hormones encoded by the proglucagon gene, which gives rise to a number of individual peptides through posttranslational processing [1-5].”
BackgroundLiraglutide, a GLP‐1 Analogue to Treat Diabetes
Knudsen, L. B. (2010) · Wiley eBooks · doi:10.1002/9783527630035.ch14 · Cited by 2
GLP-1 Receptors in Golden Syrian Hamster Islets: Identification and Functional Characterization
Rosselin, G., Leclercq-Meyer, V., Boissart, C., Pessah, M., & Malaisse, W. J. (1998) · Endocrine · doi:10.1385/endo:8:3:323 · Cited by 2
The entero-insular axis: a journey in the physiopathology of diabetes
Malaguarnera, R., Scamporrino, A., Filippello, A., Mauro, S. D., Minardo, A., Purrello, F., & Piro, S. (2020) · Exploration of Medicine · doi:10.37349/emed.2020.00025 · Cited by 2
“Proglucagon was characterized in 1983 [12] when it was observed that its amino acid sequence comprises not only glucagon and GLP-1, but also oxyntomodulin, GLP-1, glicentin, and some other elements that are still not well defined and whose functions are not yet fully understood.”
BackgroundCytotoxicity of oxide anodized titanium alloy evaluated by cell and organic culture study.
Kanematu, N., Shibata, K. I., KURENUMA, S., Watanabe, K., Yamagami, A., Nishio, Y., & Fujii, T. (1990) · PubMed · Cited by 2
GÓRSKA, A., & Arciszewski, M. B. (2020) · Medycyna Weterynaryjna · doi:10.21521/mw.6374 · Cited by 3
The Posttranslational Processing of the Precursors of Secreted Peptides
Kreil, G. (1986) · Springer series in molecular biology · doi:10.1007/978-1-4612-4930-6_4 · Cited by 2
Biosynthesis and Processing of Gastrointestinal Peptide Hormones
Beinfeld, M. C. (1999) · Humana Press eBooks · doi:10.1007/978-1-59259-695-9_2 · Cited by 2
An Overview of Gastrointestinal Endocrine Physiology
Brown, J. C. (1993) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(18)30132-4 · Cited by 2
Vaudry, H., & Nahon, J. (2009) · Peptides · doi:10.1016/j.peptides.2009.09.014 · Cited by 2
On the necessity of isolating peptides
Mutt, V. (1993) · Springer eBooks · doi:10.1007/978-94-011-1470-7_1 · Cited by 2
Ghosh, K., & Sobhia, M. E. (2022) · Research Square · doi:10.21203/rs.3.rs-1721735/v1 · Cited by 2
Analogos de GLP1: marcando nuevas rutas en el manejo de la diabetes
Casas, L. Á. (2022) · Revista Colombiana de Endocrinología Diabetes & Metabolismo · doi:10.53853/encr.9.2.754 · Cited by 2
Development of the Pancreatic B-Cells: Growth Pattern and Functional Maturation
Portha, B. (1990) · Springer eBooks · doi:10.1007/978-1-4615-9567-0_4 · Cited by 2
Kahal, H. (2013) · Repository@Hull (Worktribe) (University of Hull) · Cited by 2
Foundational contributions of Svetlana Mojsov to the GLP-1 field
Bárány, G., & Barany, M. J. (2024) · Exploration of Drug Science · doi:10.37349/eds.2024.00069 · Cited by 2
D’Alessio, D. A., & Kahn, S. E. (2024) · Diabetes · doi:10.2337/dbi24-0046 · Cited by 1
Cui, Y., Liu, B., Wu, T., Zhang, Z., & Yuan, H. (2025) · Journal of Pharmaceutical Innovation · doi:10.1007/s12247-025-10182-6 · Cited by 1
“In 1983, Graeme Bell and others cloned and sequenced the glucagon precursor gene from mammals and humans, and named the two new hormones expressed in the intestine Glucagon-like peptide-1 (GLP-1) and Glucagon-like peptide-2 (GLP-2) [5, 6].”
Portha, B., & Liu, J. (2026) · Cahiers de Nutrition et de Diététique · doi:10.1016/j.cnd.2025.12.005 · Cited by 1
Portha, B., & Liu, J. (2026) · Cahiers de Nutrition et de Diététique · doi:10.1016/j.cnd.2026.01.001 · Cited by 1
The Role of Central Nervous System Glucagon-Like Peptide-1 in the Regulation of Energy Balance
Barrera, J. G. (2009) · OhioLink ETD Center (Ohio Library and Information Network) · Cited by 1
Molecular Biology of Gluco-Incretin Function
Klinger, S., & Thorens, B. (2008) · Springer eBooks · doi:10.1007/978-4-431-75452-7_16 · Cited by 1
Effect of Bariatric Surgery on Incretin Function
Laferrère, B. (2015) · Springer eBooks · doi:10.1007/978-1-4939-3220-7_9 · Cited by 1
“About 10 years later, GLP-1 was isolated and recognized as a key incretin [ 33 ].”
BackgroundGlucagon receptor family in GtoPdb v.2021.3
BATAILLE, D., Chan, S. L. F., Delagrange, P., Drucker, D. J., Göke, B., Hills, R., Mayo, K. E., Miller, L. J., Salvatori, R., & Thorens, B. (2021) · IUPHAR/BPS Guide to Pharmacology CITE · doi:10.2218/gtopdb/f29/2021.3 · Cited by 1
“(1991) Functional receptors for the insulinotropic hormone glucagon-like peptide-I(7-37) on a somatostatin secreting cell line.”
BackgroundInfluentialGlucagon-like Peptide-1 Receptor Agonists (GLP1-RA)
Alicic, R. Z., Cox, E. J., Neumiller, J. J., & Tuttle, K. R. (2022) · Springer eBooks · doi:10.1007/978-3-030-86020-2_26 · Cited by 2
Rehfeld, J. F. (2018) · Endocrinology · doi:10.1007/978-3-319-44675-2_19 · Cited by 1
Four sidenotes about glucagon peptides
Rehfeld, J. F. (2022) · Peptides · doi:10.1016/j.peptides.2022.170924 · Cited by 1
Sequences of Natural Gut Peptides, Related Peptides, and Their Precursors
Yanaihara, C. (1989) · Comprehensive physiology · doi:10.1002/cphy.cp060202 · Cited by 1
Molecular Biology of Gut Peptides
Haun, R. S., Minth, C. D., Andrews, P., & Dixon, J. E. (1989) · Comprehensive physiology · doi:10.1002/cphy.cp060201 · Cited by 1
Das Inkretinhormon GLP-1: Eine therapeutische Option bei Typ-2-Diabetes?
Göke, B., Hoppe, B., Konrad, A., & Schirra, J. R. J. (2002) · Pharmazie in unserer Zeit · doi:10.1002/1615-1003(200205)31:3<294::aid-pauz294>3.0.co;2-1 · Cited by 2
Synthesis of Gastrointestinal Hormones Using Organic Chemical or Recombinant DNA Techniques
Yanaihara, N., & Yanaihara, C. (1988) · Advances in metabolic disorders · doi:10.1016/b978-0-12-027311-9.50009-3 · Cited by 1
The GIuco-Incretin Hormone Glucagon-Like Peptide-1 and Its β-Cell Receptor
Thorens, B. (1994) · Humana Press eBooks · doi:10.1007/978-1-4612-0241-7_15 · Cited by 2
Editorial: Trends in Comparative Endocrinology and Neurobiology
Vaudry, H., & Kah, O. (2017) · Frontiers in Endocrinology · doi:10.3389/fendo.2017.00338 · Cited by 1
Peptide Hormones in the Gastrointestinal Tract
Rehfeld, J. F. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.00050-7 · Cited by 1
Proglucagon-Derived Peptides in the Neuroendocrine System
Baibaker, P. L., Stobie, K. M., Roberge, J. N., Lui, E. Y. T., & Drucker, D. J. (1991) · Advances in experimental medicine and biology · doi:10.1007/978-1-4684-5931-9_12 · Cited by 3
BATAILLE, D. (1989) · Comprehensive physiology · doi:10.1002/cphy.cp060220 · Cited by 5
Ruokahalun säätely ja lihavuuden lääkehoito : lihavuuslääkkeiden tehoseulontamenetelmä seeprakalalla
Heine, S. (2014) · Helda - University of Helsinki Institutional Repository
英夫, 佐. (1991) · 糖尿病 · doi:10.11213/tonyobyo1958.34.933
The binding and activation of the glucagon-like peptide-1 receptor by exendin-4
Nasr, E. M. N. (2010) · White Rose eTheses Online (University of Leeds, The University of Sheffield, University of York)
Gut induced biomarkers of appetite and satiety
Meyer‐Gerspach, A. C. (2012) · edoc (University of Basel) · doi:10.5451/unibas-006055102
Islet Amyloid Polypeptide/GLP‐1/Exendin
Baggio, L. L., & Drucker, D. J. (2003) · Wiley eBooks · doi:10.1002/0470862092.d0209
Glucagon-like peptide-1 in nonalcoholic steatohepatitis
Armstrong, M. J. (2014) · University of Birmingham Institutional Research Archive (University of Birmingham)
Glucagon Synthesis with mRNA Preparation of a Glucagon-Producing Tumor (IT-1).
Sato, J. (1989) · Endocrinologia Japonica · doi:10.1507/endocrj1954.36.755
Synthesis of fragments of anglerfish pre-proglucagon i mid ii (AGFI and AGFII)
Galpin, I. J., & Leach, C. A. (1984) · Tetrahedron · doi:10.1016/s0040-4020(01)98817-9
Kershaw, E. E., Chua, S. C., & Leibel, R. L. (1995) · Mammalian Genome · doi:10.1007/bf00352422
“Glucagon-like peptide-1 (GLP-1) is produced by processing of proglucagon in intestinal L-cells ( Bell et al. 1983 ).”
BackgroundShort-term effects of glucagon-like peptide 1 (7–36 amide) on leucine kinetics in healthy volunteers
Shalev, A., & Keller, U. B. (1997) · Clinical Nutrition · doi:10.1016/s0261-5614(97)80032-5
Informationsgivning vid publika förvärv
Schönbeck, J. (2005) · Lund University Publications Student Papers (Lund University)
The neural basis of estradiol conditioned taste aversion learning and estradiol anorexia
Hintiryan, H. (2009) · University of Southern California Digital Library · doi:10.25549/usctheses-m2130
The time has come for incretins, a long time coming
Luft, F. C. (2010) · Journal of Molecular Medicine · doi:10.1007/s00109-009-0586-5
“cloned the mammalian proglucagon gene in 1983 and deduced the human proglucagon sequence [6].”
MethodVirally, M., Kévorkian, J.-P., & Guillausseau, P.-J. (2008) · Sang thrombose vaisseaux · doi:10.1684/stv.2008.0329 · Cited by 6
“Le rationnel de cette stratégie thérapeutique a été mis en évidence, en 1998, par Holst qui a démontré, sur des modèles animaux, l’action insulinotropique de l’augmentation du GLP-1 endogène par les inhibiteurs de la DPP-4 [4].”
BackgroundInfluentialMéquinion, M. (2014) · theses.fr (ABES) · doi:10.70675/8164dbbcz3c72z46f4za0d8z22289b73b5e3 · Cited by 1
“Alors que le glucagon subit sa maturation au niveau du pancréas, GLP-1 et GLP-2 sont produits au niveau de l’intestin et du NTS par clivage protéolytique (Bell et al., 1983 ; Larsen et al., 1997).”
BackgroundHerzig, K., Otte, J., & Fölsch, U. R. (1999) · Springer eBooks · doi:10.1007/978-3-642-59960-6_58
Heinrich, G., & Habener, J. F. (1987) · Humana Press eBooks · doi:10.1007/978-1-4612-4824-8_4
The History of GLP-1 and the Debate Regarding Its Tissue-Specific Expression
Fava, G. E., & Wu, H. (2014)
Regulation of glucagon secretion from pancreatic alpha cells
Marinis, Y. Z. D. (2010) · Lund University Publications (Lund University)
The effects of DPP-4 inhibitors on vascular endothelial function in diabetes
Salheen, S. M. (2015) · RMIT Research Repository (RMIT University Library) · doi:10.25439/rmt.27591369
Farah, L. X. S. (2015) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.5.2015.tde-05102015-114814
Widenmaier, S. B. (2010) · cIRcle (University of British Columbia) · doi:10.14288/1.0071070
“Bell and colleagues (Bell et al., 1983) were the first to isolate mammalian preproglucagon cDNA and they discovered two glucagon-related peptides arranged in tandem, one of which was structurally similar to that of the anglerfish, and they named them glucagonlike peptide-1 (GLP-1) and glucagon-like…”
BackgroundExtrapancreatic actions of incretin-based therapies on bone in diabetes mellitus
Mansur, S. A. (2015) · UTHM Institutional Repository (Universiti Tun Hussein Onn Malaysia)
Köthe, L. (2011) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-1062
Merchant, C. E. (2011) · cIRcle (University of British Columbia) · doi:10.14288/1.0105089
“…GLP-1 was identified following the discovery of two glucagon-related sequences in angler fish preproglucagon cDNA (Lund, 2005; Lund et al., 1982), and the cloning and sequencing of the mammalian proglucagon gene (Bell et al., 1983a; Bell et al., 1983b; Heinrich et al., 1984; Lopez et al., 1983).”
BackgroundPaulo, S., & Girardi, C. (2015)
Gut peptides in gastrointestinal motility and mucosal permeability
Halim, M. A. (2016) · DiVA (Digitala Vetenskapliga Arkivet)
Johnston, K. L. (2003) · Surrey Research Insight Open Access (The University of Surrey)
Glucagon like peptide-1 (glp-1) in myocardial ischaemia-reperfusion injury.
Bose, A. (2006) · OpenGrey (Institut de l'Information Scientifique et Technique)
Endocrinology of the Gastrointestinal Tract and Modulation of Satiety
Burcelin, R., & Cani, P. D. (2008) · CRC Press eBooks · doi:10.1201/9780849381829.ch11
Peptide-secreting Tumours of the Gut
UTTENTHAL, L. O. (1984) · Elsevier eBooks · doi:10.1016/b978-0-433-30277-3.50015-4
Incretin hormones as a target for therapy
Holst, J. J. (2016) · Springer eBooks · doi:10.1007/978-3-319-08982-9_2
Abbreviated Title: Extra-Pancreatic Effects of GLP-1
Abu‐Hamdah, R., Rabiee, A., Meneilly, G. S., Shannon, R. P., & Elahi, D. (2009)
Central Regulation of Food Intake of Chicks
Bungo, T. (2001) · Japanese poultry science · doi:10.2141/jpsa.38.j131
Paracrine regulation of glucagon secretion from pancreatic islets
Elliott, A. D. (2014)
GI Peptides, Energy Balance, and Cancer
Bruno, D. S., & Wolfe, M. M. (2016) · Energy balance and cancer · doi:10.1007/978-3-319-41677-9_11
Therapeutic potential of GLP-1 for treatment of diabetes
Meenakshi, & Kumar, A. N. (2015) · International journal of applied research
The role of gut hormones on food intake and carbohydrate tolerance
Tharakan, G. (2016) · Spiral (Imperial College London) · doi:10.25560/41846
“Pro-glucagon, the precursor of glucagon, was identified in 1983 by Bell et al(50).”
BackgroundGhiglione, M., Rovira, A., Garrote, F. J., & Valverde, I. (1985) · Biomedical Research · doi:10.2220/biomedres.6.367
The Role of p21-activated Protein Kinase 1 in Metabolic Homeostasis
Chiang, Y. P. (2014) · TSpace (University of Toronto)
Metadata
- Authors
- Bell, G. I., Santerre, R. F., & Mullenbach, G. T.
- Affiliations
- Eli Lilly (United States) (US)
- Venue
- Nature
- Published
- 1983-04
- Volume
- 302
- Issue
- 5910
- Pages
- 716-718
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2061274996
- Cited by
- 649
- References
- 35
- Citations by year
- 2026: 22 · 2025: 22 · 2024: 22 · 2023: 9 · 2022: 16 · 2021: 20 · 2020: 8 · 2019: 16 · 2018: 16 · 2017: 8 · 2016: 18 · 2015: 13 · 2014: 21 · 2013: 12 · 2012: 9
- FWCI
- 41.99
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- proglucagon, glucagon, hamster, pancreatic A cells, cDNA sequence, precursor processing
- MeSH terms
- Amino Acid Sequence, Animals, Base Sequence, Fishes, Glucagon, Cricetinae, Molecular Weight, Protein Precursors, RNA, Messenger, Species Specificity, Proglucagon
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.